{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:12:07Z","timestamp":1775909527910,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s00467-006-0223-2","type":"journal-article","created":{"date-parts":[[2006,8,14]],"date-time":"2006-08-14T09:54:22Z","timestamp":1155549262000},"page":"1716-1722","source":"Crossref","is-referenced-by-count":39,"title":["Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors"],"prefix":"10.1007","volume":"21","author":[{"given":"Mieczys\u0142aw","family":"Litwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryszard","family":"Grenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"\u015aladowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Antoniewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"223_CR1","first-page":"7","volume":"14","author":"L Vecchio Del","year":"2001","unstructured":"Del Vecchio L, Locatelli F (2001) The renoprotective effect of combined antihypertensive drugs. J Nephrol 14:7\u201314","journal-title":"J Nephrol"},{"key":"223_CR2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s004670050373","volume":"11","author":"G Lama","year":"1997","unstructured":"Lama G, Salsano ME, Pedulla\u2019 M, Grassia C, Ruocco G (1997) Angiotensin converting enzyme inhibitors and reflux nephropathy: a 2-year follow-up. Pediatr Nephrol 11:714\u2013718","journal-title":"Pediatr Nephrol"},{"key":"223_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0022-3476(88)80073-8","volume":"112","author":"H Trachtman","year":"1988","unstructured":"Trachtman H, Gauthier B (1988) Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112:295\u2013298","journal-title":"J Pediatr"},{"key":"223_CR4","first-page":"89","volume":"18","author":"LM Ruilope","year":"2000","unstructured":"Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF (2000) Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. J Hypertens 18:89\u201395","journal-title":"European Group for the Investigation of Valsartan in Chronic Renal Disease J Hypertens"},{"key":"223_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1159\/000081953","volume":"24","author":"N Nakao","year":"2004","unstructured":"Nakao N, Seno H, Kasuga H, Toriyama T, Kawahara H, Fukagawa M (2004) Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy. Am J Nephrol 24:543\u2013548","journal-title":"Am J Nephrol"},{"key":"223_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","volume":"361","author":"N Nakao","year":"2003","unstructured":"Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361:117\u2013124","journal-title":"Lancet"},{"key":"223_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/ajkd.2001.22069","volume":"37","author":"T Shiigai","year":"2001","unstructured":"Shiigai T, Schichiri M (2001) Late escape from the antiproteinuric effect of ACE inhibitors in nondiabetic renal disease. Am J Kid Dis 37:477\u2013483","journal-title":"Am J Kid Dis"},{"key":"223_CR8","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1093\/ndt\/gfh384","volume":"19","author":"P Kincaid-Smith","year":"2004","unstructured":"Kincaid-Smith P, Fairley KF, Packham D (2004) Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure. Nephrol Dial Transplant 19:2272\u20132274","journal-title":"Nephrol Dial Transplant"},{"key":"223_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 114:555\u2013576","journal-title":"Pediatrics"},{"key":"223_CR10","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1523-1755.2004.00802.x","volume":"66","author":"E Wuhl","year":"2004","unstructured":"Wuhl E, Mehls O, Schaefer F; ESCAPE Trial Group (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768\u2013776","journal-title":"Kidney Int"},{"key":"223_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00467-004-1451-y","volume":"19","author":"M Dyck Van","year":"2004","unstructured":"Van Dyck M, Proesmans W (2004) Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Pediatr Nephrol 19:688\u2013690","journal-title":"Pediatr Nephrol"},{"key":"223_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00467-003-1329-4","volume":"19","author":"M Litwin","year":"2004","unstructured":"Litwin M (2004) Risk factors for renal failure in children with non-glomerular nephropathies. Pediatr Nephrol 19:178\u2013186","journal-title":"Pediatr Nephrol"},{"key":"223_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2369-3-2","volume":"3","author":"L Adler","year":"2002","unstructured":"Adler L, Mathew R, Futterweit S, Frank R, Gauthier BG, Kashtan CE, Trachtman H (2002) Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta and nitrite excretion. BMC Nephrol 3:2","journal-title":"BMC Nephrol"},{"key":"223_CR14","unstructured":"Holmberg C, Trygvasson K, Kestila MK, Jalanko HJ (2004) Congenital nephrotic syndrome. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology, 5th edn. Lippincot Wiliams & Wilkins, pp 503\u2013516"},{"key":"223_CR15","first-page":"104","volume":"14","author":"RM Hamed","year":"2002","unstructured":"Hamed RM, Shomaf M (2002) Congenital nephritic syndrome: a clinico-pathological study of 30 children. J Nephrol 14:104\u2013109","journal-title":"J Nephrol"},{"key":"223_CR16","first-page":"928","volume":"17","author":"D Ellis","year":"2004","unstructured":"Ellis D, Moritz ML, Vats A, Janosky JE (2004) Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders. Am J Hypertens 17:928\u2013935","journal-title":"Am J Hypertens"},{"key":"223_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00238.x","volume":"64","author":"AC Gartenmann","year":"2003","unstructured":"Gartenmann AC, Fossali E, von Vigier RO, Simonetti GD, Schmidtko J, Edefonti A, Bianchetti MG (2003) Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int 64:1450\u20131454","journal-title":"Kidney Int"},{"key":"223_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1442-200x.2004.01955.x","volume":"46","author":"H Tanaka","year":"2004","unstructured":"Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S (2004) Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. Pediatr Int 46:576\u2013579","journal-title":"Pediatr Int"},{"key":"223_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5414\/CNP64035","volume":"64","author":"Y Yang","year":"2005","unstructured":"Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S (2005) Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clin Nephrol 64:35\u201340","journal-title":"Clin Nephrol"},{"key":"223_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0272-6386(96)90158-4","volume":"27","author":"BU Ihle","year":"1996","unstructured":"Ihle BU, Whitwirth JA, Shahinfar S, Cnaan A, Kincaid-Smith PS, Becker GJ (1996) Angiotensin-converting enzyme inhibition in non-diabetic progressive renal insufficiency: a controlled double-blind trial. Am J Kidney Dis 27:489\u2013495","journal-title":"Am J Kidney Dis"},{"key":"223_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJMoa053107","volume":"354","author":"FF Hou","year":"2006","unstructured":"Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Gang RW (2006) Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Eng J Med 354:131\u2013140","journal-title":"N Eng J Med"},{"key":"223_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.amjhyper.2004.09.009","volume":"18","author":"S Shahinfar","year":"2005","unstructured":"Shahinfar S, Cano F, Sofffer BA, Ahmed T, Santoro EP, Zhang Z, Gleim G, Miller K, Vogt B, Blumer J, Biezogounov J (2005) A double-blind, dose-response study of losartan in hypertensive children. Am J Hypertens 18:183\u2013190","journal-title":"Am J Hypertens"},{"key":"223_CR23","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/j.1523-1755.2005.00511.x","volume":"68","author":"K Rossing","year":"2005","unstructured":"Rossing K, Schjoedt KJ, Jensen BR, Boomsma F, Parving HH (2005) Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 68:1190\u20131198","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-006-0223-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0223-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-006-0223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T01:33:52Z","timestamp":1574300032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-006-0223-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1007\/s00467-006-0223-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}